Related Experiment Video
Updated: Mar 8, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Tight Glycemic Control in Critically Ill Children
Michael S D Agus1, David Wypij1, Eliotte L Hirshberg1
1From the Division of Medicine Critical Care (M.S.D.A., J.L.A., G.M.S.) and the Department of Cardiology (D.W., L.A.A.), Boston Children's Hospital and Harvard Medical School, Boston; the Division of Pediatric Critical Care, University of Utah Medical School, Primary Children's Hospital, Salt Lake City, and Intermountain Medical Center, Murray - both in Utah (E.L.H.); Children's Hospital of Philadelphia (V.S., V.M.N.) and the Perelman School of Medicine (V.S., M.A.Q.C., V.M.N.) and the School of Nursing (M.A.Q.C.), University of Pennsylvania - all in Philadelphia; Yale School of Medicine, New Haven, CT (E.V.F.); and Children's Medical Center Dallas and the University of Texas Southwestern Medical School, Dallas (P.M.L.).
Insights
Tight glycemic control in critically ill children without cardiac surgery did not improve intensive care unit (ICU)-free days. This approach was associated with increased infections and severe hypoglycemia, suggesting it may cause harm.
Area of Science:
- Pediatric Critical Care Medicine
- Endocrinology
- Clinical Trials
Background:
- Previous studies showed no benefit of tight glycemic control in critically ill adults and children post-cardiac surgery.
- Limited data exists on glycemic control in critically ill children not undergoing cardiac surgery.
Purpose of the Study:
- To investigate the efficacy and safety of tight glycemic control versus a higher target range in critically ill children with hyperglycemia who have not undergone cardiac surgery.
Main Methods:
- A 35-center randomized trial assigned critically ill children with hyperglycemia to a lower (80-110 mg/dL) or higher (150-180 mg/dL) glycemic control target.
- Continuous glucose monitoring and explicit insulin adjustment protocols were used.
- The primary outcome was intensive care unit (ICU)-free days to day 28.
Main Results:
- The trial was stopped early due to low likelihood of benefit and potential harm.
- No significant difference in median ICU-free days was observed between the lower-target and higher-target groups (19.4 days vs. 19.4 days).
- The lower-target group had higher rates of healthcare-associated infections (3.4% vs. 1.1%) and severe hypoglycemia (5.2% vs. 2.0%).
Conclusions:
- Tight glycemic control targeting 80-110 mg/dL offers no benefit and may increase harm in critically ill children with hyperglycemia compared to a higher target of 150-180 mg/dL.
- The findings suggest that a less stringent glycemic control strategy is appropriate for this patient population.
Background:
In multicenter studies, tight glycemic control targeting a normal blood glucose level has not been shown to improve outcomes in critically ill adults or children after cardiac surgery. Studies involving critically ill children who have not undergone cardiac surgery are lacking.
Methods:
In a 35-center trial, we randomly assigned critically ill children with confirmed hyperglycemia (excluding patients who had undergone cardiac surgery) to one of two ranges of glycemic control: 80 to 110 mg per deciliter (4.4 to 6.1 mmol per liter; lower-target group) or 150 to 180 mg per deciliter (8.3 to 10.0 mmol per liter; higher-target group). Clinicians were guided by continuous glucose monitoring and explicit methods for insulin adjustment. The primary outcome was the number of intensive care unit (ICU)-free days to day 28.
Results:
The trial was stopped early, on the recommendation of the data and safety monitoring board, owing to a low likelihood of benefit and evidence of the possibility of harm. Of 713 patients, 360 were randomly assigned to the lower-target group and 353 to the higher-target group. In the intention-to-treat analysis, the median number of ICU-free days did not differ significantly between the lower-target group and the higher-target group (19.4 days [interquartile range {IQR}, 0 to 24.2] and 19.4 days [IQR, 6.7 to 23.9], respectively; P=0.58). In per-protocol analyses, the median time-weighted average glucose level was significantly lower in the lower-target group (109 mg per deciliter [IQR, 102 to 118]; 6.1 mmol per liter [IQR, 5.7 to 6.6]) than in the higher-target group (123 mg per deciliter [IQR, 108 to 142]; 6.8 mmol per liter [IQR, 6.0 to 7.9]; P<0.001). Patients in the lower-target group also had higher rates of health care-associated infections than those in the higher-target group (12 of 349 patients [3.4%] vs. 4 of 349 [1.1%], P=0.04), as well as higher rates of severe hypoglycemia, defined as a blood glucose level below 40 mg per deciliter (2.2 mmol per liter) (18 patients [5.2%] vs. 7 [2.0%], P=0.03). No significant differences were observed in mortality, severity of organ dysfunction, or the number of ventilator-free days.
Conclusions:
Critically ill children with hyperglycemia did not benefit from tight glycemic control targeted to a blood glucose level of 80 to 110 mg per deciliter, as compared with a level of 150 to 180 mg per deciliter. (Funded by the National Heart, Lung, and Blood Institute and others; HALF-PINT ClinicalTrials.gov number, NCT01565941 .).
More Related Videos
Related Concept Videos
Hypoglycemia and Glucagon
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Acute Pancreatitis II: Clinical Manifestations and Management
Diabetes Mellitus: Type 2 and Gestational

